The overall goal of this training program is to attract and train talented under-represented minority pre- doctoral students to MSM and prepare them to pursue independent research career opportunities in Clinical and Translational Research (CTR) thereby augmenting the number of highly skilled investigators pursuing CTR related to clinical cardiovascular disease and sleep disorders. The following aims will drive the overall goal of this program:
Aim 1 : Develop a multidisciplinary clinical cardiovascular and sleep-disorders research training program that will recruit URM candidates across the ACTSI and its partner institutions (MSM, Emory, and Georgia Tech). We will target PhD graduate students interested in cardiovascular and sleep disorders research for enrollment in the PhD/MSCR track in the MSM MSCR program, and target medical students interested in cardiovascular and sleep disorders research for enrollment in the MD/MSCR track in the MSM MSCR program.
Aim 2 : Enhance the clinical and translational research training environment in cardiovascular and sleep disorders for minority T32 trainees. We will promote interdisciplinary discourse and scientific exchange among T32 trainees, faculty and mentors. We will harnesses the diversity and strength of MSM graduate medical education programs, the basic science research excellence ofthe Cardiovascular and Neuroscience institutes, the outstanding clinical research resources and mentorship ofthe Atlanta Clinical and Translational Science Institute (ACTSI) to address the above aims.

Public Health Relevance

This training program addresses the critical need for development of a sustainable pool of minority scientists as leading investigators for the 21 st century, by developing and implementing innovative strategies and collaborations that build upon the strengths of existing programs such as the ACTSI.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-CSR-H (M2))
Program Officer
Carlson, Drew E
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Morehouse School of Medicine
Organized Research Units
United States
Zip Code
Owino, Sharon; Sánchez-Bretaño, Aida; Tchio, Cynthia et al. (2018) Nocturnal activation of melatonin receptor type 1 signaling modulates diurnal insulin sensitivity via regulation of PI3K activity. J Pineal Res 64:
Estape, Estela S; Quarshie, Alexander; Segarra, Barbara et al. (2018) Promoting Diversity in the Clinical and Translational Research Workforce. J Natl Med Assoc 110:598-605
O'Bryant, Zaven; Leng, Tiandong; Liu, Mingli et al. (2016) Acid Sensing Ion Channels (ASICs) in NS20Y cells - potential role in neuronal differentiation. Mol Brain 9:68
Lipsey, Crystal C; Harbuzariu, Adriana; Daley-Brown, Danielle et al. (2016) Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer. World J Methodol 6:43-55
Salifu, Hassana; Wilson, Nana O; Liu, Mingli et al. (2016) Iron Supplementation Alters Heme and Heme Oxygenase 1 (HO-1) Levels In Pregnant Women in Ghana. SOJ Microbiol Infect Dis 4:
Richards, Jendai; Ogoe, Henry Ato; Li, Wenzhi et al. (2016) DNA Methylation Signature of Post-injury Neointimal Cells During Vascular Remodeling in the Rat Balloon Injury Model. Mol Biol (Los Angel) 5:
Scott, Takara A; Babayeva, Oguljahan; Banerjee, Saswati et al. (2016) SGK1 is modulated by resistin in vascular smooth muscle cells and in the aorta following diet-induced obesity. Obesity (Silver Spring) 24:678-86
Daley-Brown, Danielle; Oprea-Ilies, Gabriela M; Lee, Regina et al. (2015) Molecular cues on obesity signals, tumor markers and endometrial cancer. Horm Mol Biol Clin Investig 21:89-106
Dickinson-Copeland, Carmen M; Wilson, Nana O; Liu, Mingli et al. (2015) Heme-Mediated Induction of CXCL10 and Depletion of CD34+ Progenitor Cells Is Toll-Like Receptor 4 Dependent. PLoS One 10:e0142328
Tosini, Gianluca; Owino, Sharon; Guillaume, Jean-Luc et al. (2014) Understanding melatonin receptor pharmacology: latest insights from mouse models, and their relevance to human disease. Bioessays 36:778-87

Showing the most recent 10 out of 11 publications